Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.


TSXV:VPT - Post by User

Post by jopatcloon Jul 18, 2024 12:59pm
152 Views
Post# 36138630

The next wave of breakthroughs in healthcare,

The next wave of breakthroughs in healthcare,
GE HealthCareGE 2,265,627 followers1 hour ago
What happens when leaders in medical technology and AI-driven image analysis tools come together?
Today, GE HealthCare announced an agreement to acquire Intelligent Ultrasound's clinical AI business, supporting our precision care strategy and mission to empower clinicians with solutions that improve patient care quality. 
With artificial intelligence at the forefront of the next wave of breakthroughs in healthcare, the advancement of AI-enabled ultrasound technologies brings us closer to a world where healthcare has no limits.

https://lnkd.in/g5RyNcpb I really believe that we are at the start of a wave of AI making a profound difference to medical imaging, and especially ultrasound,” said Nick Sleep, Chief Operating Officer, Intelligent Ultrasound, who will join GE HealthCare. “Becoming part of the GE HealthCare family will help speed the adoption of this technology and make ultrasound even easier for customers to use.”
https://lnkd.in/g5RyNcpb
<< Previous
Bullboard Posts
Next >>